tiprankstipranks
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market
Holding RNA?
Track your performance easily

Avidity Biosciences (RNA) Financial Statements

688 Followers

Avidity Biosciences Financial Overview

Avidity Biosciences's market cap is currently ―. The company's EPS TTM is $-2.898; its P/E ratio is -14.55; Avidity Biosciences is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.76. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 2.34M$ 2.04M$ 3.54M$ 2.19M$ 2.82M
Gross Profit$ 2.34M$ 2.04M$ 3.54M$ 2.19M$ 2.82M
EBIT$ -80.40M$ -70.79M$ -77.19M$ -66.74M$ -58.63M
EBITDA$ -78.88M$ -66.31M$ -76.55M$ -66.13M$ -58.06M
Net Income Common Stockholders$ -80.40M$ -70.79M$ -68.86M$ -60.44M$ -52.36M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.59B$ 1.30B$ 915.87M$ 595.35M$ 542.58M
Total Assets$ 1.64B$ 1.35B$ 951.47M$ 628.55M$ 573.16M
Total Debt$ 7.60M$ 8.38M$ 9.15M$ 9.85M$ 10.58M
Net Debt$ -1.58B$ -1.29B$ -906.73M$ -585.50M$ -532.00M
Total Liabilities$ 137.39M$ 126.39M$ 120.58M$ 127.79M$ 55.70M
Stockholders Equity$ 1.50B$ 1.22B$ 830.92M$ 500.76M$ 517.47M
Cash Flow-
Free Cash Flow$ -67.32M$ -65.53M$ -71.30M$ 15.64M$ -37.71M
Operating Cash Flow$ -65.61M$ -65.00M$ -70.38M$ 16.50M$ -36.79M
Investing Cash Flow$ -482.41M$ -274.87M$ -32.75M$ 51.04M$ -31.48M
Financing Cash Flow$ 342.46M$ 446.72M$ 389.44M$ 31.89M$ 40.00K
Currency in USD

Avidity Biosciences Earnings and Revenue History

Avidity Biosciences Debt to Assets

Avidity Biosciences Cash Flow

Avidity Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis